bpc-157 safety human studies Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review bpc-157 human studies clinical trials

Semaglutide has robust randomized trial evidence and an FDA weight loss indication

There is a chance that peptides besides GLP-1s will eventually be demonstrated to provide health outcome benefits as seen in rodent pre-clinical models

Attan, C

All of the injured rats that received BPC 157 exhibited consistent clinical improvement, increasingly better motor function of the tail, no autotomy, and resolved spasticity by day 15

4a indicated that BPC 157 at 1 g/ml could increase the nitric oxide production in vascular endothelial cells up to 1.35 0.1-fold compared with control

Pair with a balanced, protein-adequate diet to support muscle synthesis and recovery